IKK-β links inflammation to obesity-induced insulin resistance
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Inflammation may underlie the metabolic disorders of insulin resistance and type 2 diabetes. IkappaB kinase beta (IKK-beta, encoded by Ikbkb) is a central coordinator of inflammatory responses through activation of NF-kappaB. To understand the role of IKK-beta in insulin resistance, we used mice lacking this enzyme in hepatocytes (Ikbkb(Deltahep)) or myeloid cells (Ikbkb(Deltamye)). Ikbkb(Deltahep) mice retain liver insulin responsiveness, but develop insulin resistance in muscle and fat in response to high fat diet, obesity or aging. In contrast, Ikbkb(Deltamye) mice retain global insulin sensitivity and are protected from insulin resistance. Thus, IKK-beta acts locally in liver and systemically in myeloid cells, where NF-kappaB activation induces inflammatory mediators that cause insulin resistance. These findings demonstrate the importance of liver cell IKK-beta in hepatic insulin resistance and the central role of myeloid cells in development of systemic insulin resistance. We suggest that inhibition of IKK-beta, especially in myeloid cells, may be used to treat insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“failure to effectively resolve inflammation leading to a chronic state of inflammation is associated with IR/T2D and obesity [79,143].”
From Omega-3 Fatty Acids and Skeletal Muscle Health (2015) · cites this paper as [143]
In the citing paper
“Along these lines, numerous insulin-resistant states (e.g., obesity, type 2 diabetes, and lipid/heparin infusion) are associated with increased activation of JNK (18,21) and/or IKK (21)(22)(23)(24)(25) in parallel with inhibitory serine phosphorylation of IRS-1 (18,21).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [24]
In the citing paper
“In contrast, inhibition or inactivation of JNK (18,26) or IKK (22,24,25,27) improves insulin sensitivity in various models of insulin resistance in association with reduced inhibitory serine phosphorylation of IRS-1 (18).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [24]
In the citing paper
“Accordingly, KO or inhibition of JNK1 or IKKβ prevents insulin resistance in cell and mouse models (18,22,24,25,87) as well as human models (27) of insulin resistance.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [24]
In the citing paper
“The results showed that myeloid cell KO of IKKβ or JNK1 protected mice from HFD-induced glucose intolerance, hyperinsulinemia, and insulin resistance in skeletal muscle, adipose tissue, and the liver (24,87).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [24]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419 · cited 1×
“to quantify these functions in two separate models: Ikbkb Δhep mice on HFD and Ikbkb Δhep mice rendered homozygous for the ob mutation, causing leptin deficienc”
MethodObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“In addition, many of the genes upregulated within fat during obesity are expressed in macrophage”
BackgroundXu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 1×
“Indeed, it was suggested that chronic inflammation contributes to obesity-induced insulin resistance through macrophage infiltration of fat depot”
BackgroundGlobal and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“, has increased considerably in recent years, reaching epidemic proportion”
BackgroundNuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
Barnes, P. J., & Karin, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361506 · Cited by 4,669
Self-citationNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Self-citationObesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Self-citationLocal and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Research works printed but not linked: 1
- Maeda, S. et al. IKKβ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFα. Immunity 19, 725–737 (2003). · DOI · Paper page
Cited by
Items 501–600 of 1,004
Carpi, S., Scoditti, E., Massaro, M., Polini, B., Manera, C., Digiacomo, M., Salsano, J. E., Poli, G., Tuccinardi, T., Doccini, S., et al. (2019) · Nutrients · doi:10.3390/nu11122855 · Cited by 120
Self-citationOverman, A., Chuang, C.-C., & McIntosh, M. (2011) · International Journal of Obesity · doi:10.1038/ijo.2010.272 · Cited by 131
Diet-induced obesity increases NF-κB signaling in reporter mice
Carlsen, H., Haugen, F., Zadelaar, S., Kleemann, R., Kooistra, T., Drevon, C. A., & Blomhoff, R. (2009) · Genes & Nutrition · doi:10.1007/s12263-009-0133-6 · Cited by 120
Luo, N., Liu, J., Chung, B. H., Yang, Q., Klein, R. L., Garvey, W. T., & Fu, Y. (2010) · Diabetes · doi:10.2337/db09-1338 · Cited by 112
Oliveira, A. G., Araujo, T. G., Carvalho, B. M., Guadagnini, D., Rocha, G. Z., Bagarolli, R. A., Carvalheira, J. B. C., & Saad, M. J. A. (2013) · Obesity · doi:10.1002/oby.20402 · Cited by 111
Vallerie, S. N., Furuhashi, M., Fucho, R., & Hotamisligil, G. S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003151 · Cited by 111
Inactivation of NF-κB p65 (RelA) in Liver Improves Insulin Sensitivity and Inhibits cAMP/PKA Pathway
Ke, B., Zhao, Z., Ye, X., Gao, Z., Manganiello, V. C., Wu, B., & Ye, J. (2015) · Diabetes · doi:10.2337/db15-0242 · Cited by 112
Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
Li, A. A., Ahmed, A., & Kim, D. (2020) · Gut and Liver · doi:10.5009/gnl19069 · Cited by 107
Mauer, J., Chaurasia, B., Plum, L., Quast, T., Hampel, B., Blüher, M., Kolanus, W., Kahn, C. R., & Brüning, J. C. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000938 · Cited by 110
Functional Food Targeting the Regulation of Obesity-Induced Inflammatory Responses and Pathologies
Hirai, S., Takahashi, N., Goto, T., Lin, S., Uemura, T., Yu, R., & Kawada, T. (2010) · Mediators of Inflammation · doi:10.1155/2010/367838 · Cited by 109
“In activated macrophages, inflammatory responses are regulated by master regulators of inflammation such as nuclear factor-κB (NF-κB) and c-Jun amino-terminal kinase (JNK) [5, 6].”
BackgroundHe, J., Usui, I., Ishizuka, K., Kanatani, Y., Hiratani, K., Iwata, M., Bukhari, A., Haruta, T., Sasaoka, T., & Kobayashi, M. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0107 · Cited by 108
Lasram, M. M., Dhouib, I. B., Annabi, A. B., Fazâa, S. E., & Gharbi, N. (2014) · Toxicology · doi:10.1016/j.tox.2014.04.009 · Cited by 112
Magee, N., Zou, A., & Zhang, Y. (2016) · BioMed Research International · doi:10.1155/2016/5170402 · Cited by 107
Tsaousidou, E., Paeger, L., Belgardt, B. F., Pal, M., Wunderlich, C. M., Brönneke, H., Collienne, U., Hampel, B., Wunderlich, F. T., Schmidt-Supprian, M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.045 · Cited by 107
AMPK and the Endocrine Control of Metabolism
Townsend, L. K., & Steinberg, G. R. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad012 · Cited by 119
Regulation of glucose/lipid metabolism and insulin sensitivity by interleukin-4
Chang, Y.-H., Ho, K.-T., Lu, S.-H., Huang, C.-N., & Shiau, M.-Y. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.168 · Cited by 116
Sheng, L., Zhou, Y., Chen, Z., Ren, D., Cho, K. W., Jiang, L., Shen, H., Sasaki, Y., & Rui, L. (2012) · Nature Medicine · doi:10.1038/nm.2756 · Cited by 107
Romagnoli, M., Gómez‐Cabrera, M. C., Perrelli, M.-G., Biasi, F., Pallardó, F. V., Sastre, J., Poli, G., & Viña, J. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.03.024 · Cited by 120
Self-citationNAFLD, Obesity, and Bariatric Surgery
Angulo, P. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.041 · Cited by 124
Ding, J., Reynolds, L. M., Zeller, T., Müller, C., Lohman, K., Nicklas, B. J., Kritchevsky, S. B., Huang, Z., de la Fuente, A., Soranzo, N., et al. (2015) · Diabetes · doi:10.2337/db14-1314 · Cited by 112
Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data
Serfaty, L., & Capeau, J. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01952.x · Cited by 118
Wunderlich, F. T., Luedde, T., Singer, S., Schmidt-Supprian, M., Baumgartl, J., Schirmacher, P., Pasparakis, M., & Brüning, J. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707849104 · Cited by 105
Alternatively Activated Macrophages in Types 1 and 2 Diabetes
Espinoza-Jiménez, A., Peón, A. N., & Terrazas, L. I. (2012) · Mediators of Inflammation · doi:10.1155/2012/815953 · Cited by 101
Expanding the View of IKK: New Substrates and New Biology
Antonia, R. J., Hagan, R. S., & Baldwin, A. S. (2021) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.12.003 · Cited by 113
Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
Sathyapalan, T., & Atkin, S. L. (2010) · Mediators of Inflammation · doi:10.1155/2010/758656 · Cited by 103
“[20] M.”
BackgroundMechanism for Improved Insulin Sensitivity after Gastric Bypass Surgery
Bikman, B. T., Zheng, D., Pories, W. J., Chapman, W. H. H., Pender, J. R., Bowden, R., Reed, M. A., Cortright, R. N., Tapscott, E. B., Houmard, J. A., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1030 · Cited by 121
“results in deficient insulin signal transduction, given that it has been shown to phosphorylate IRS-1 on Ser (8, 9, 11, 12).”
BackgroundKang, W., Hong, H. J., Guan, J., Kim, D. G., Yang, E.-J., Koh, G., Park, D.-B., Han, C. H., Lee, Y. J., & Lee, D.-H. (2011) · Metabolism · doi:10.1016/j.metabol.2011.08.003 · Cited by 110
“[26] Arkan MC, Hevener AL, Greten FR, et al.”
BackgroundThe inflammatory status of the elderly: The intestinal contribution
Schiffrin, E. J., Morley, J. E., Donnet‐Hughes, A., & Guigoz, Y. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.07.011 · Cited by 116
Mice Chronically Fed High-Fat Diet Have Increased Mortality and Disturbed Immune Response in Sepsis
Strandberg, L., Verdrengh, M., Enge, M., Andersson, N., Amu, S., Önnheim, K., Benrick, A., Brisslert, M., Bylund, J., Bokarewa, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007605 · Cited by 103
Nontelomeric Role for Rap1 in Regulating Metabolism and Protecting against Obesity
Yeung, F., Ramírez, C. M., Mateos‐Gómez, P. A., Pinzaru, A. M., Ceccarini, G., Kabir, S., Fernandez-Hernando, C. F., & Sfeir, A. J. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.05.032 · Cited by 105
Suppressing adipocyte inflammation promotes insulin resistance in mice
Zhu, Q., An, Y. A., Kim, M., Zhang, Z., Zhao, S., Zhu, Y., Asterholm, I. W., Kusminski, C. M., & Scherer, P. E. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101010 · Cited by 99
Targeted delivery of curcumin for treating type 2 diabetes
Maradana, M. R., Thomas, R., & O’Sullivan, B. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200791 · Cited by 108
Lim, A. K. H., Ma, F. Y., Nikolic‐Paterson, D. J., Thomas, M. C., Hurst, L., & Tesch, G. H. (2009) · Diabetologia · doi:10.1007/s00125-009-1399-3 · Cited by 102
Zhang, W., Wang, L.-W., Wang, L., Li, X., Zhang, H., Luo, L., Song, J.-C., & Gong, Z. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2775-x · Cited by 108
Insulin Resistance in the Defense against Obesity
Saltiel, A. R. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.001 · Cited by 116
Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases
Cai, J., Xu, M. M., Zhang, X., & Li, H. (2018) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-013003 · Cited by 108
Chakrabarti, S. K., Wen, Y., Dobrian, A. D., Cole, B. K., Ma, Q., Pei, H., Williams, M. D., Bevard, M. H., Vandenhoff, G. E., Keller, S. R., et al. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00203.2010 · Cited by 101
Mechanism of ER Stress and Inflammation for Hepatic Insulin Resistance in Obesity
Kim, O., Jun, W., & Lee, J. (2015) · Annals of Nutrition and Metabolism · doi:10.1159/000440905 · Cited by 119
Ryan, M. C., Abbasi, F., Lamendola, C., Carter, S., & McLaughlin, T. L. (2007) · Diabetes Care · doi:10.2337/dc06-2169 · Cited by 100
Alam, I., Ng, T. P., & Larbi, A. (2012) · Mediators of Inflammation · doi:10.1155/2012/456456 · Cited by 120
“Although the nature of detailed mechanisms underlying these pathways is still in doubts, there have been some reports of the possible causes of this impact on carbohydrate metabolism that are attributed to deletion of either JNK [61] or inhibition of IKK [13, 60, 63] or even neutralization of TNF-α [40] or IL-1 [64].”
BackgroundNew therapeutic approaches for the treatment of obesity
Saltiel, A. R. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad1811 · Cited by 102
Zhou, H., Feng, L., Xu, F., Sun, Y., Ma, Y., Zhang, X., Liu, H., Xu, G., Wu, X., Shen, Y., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.003 · Cited by 108
Vesković, M. N., Šutulović, N., Hrnčić, D., Stanojlović, O. P., Μacut, D., & Mladenović, D. R. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45110570 · Cited by 115
Reversal of aging by NFκB blockade
Adler, A. S., Kawahara, T. L. A., Segal, E., & Chang, H. Y. (2008) · Cell Cycle · doi:10.4161/cc.7.5.5490 · Cited by 99
Bassaganya-Riera, J., Misyak, S., Guri, A. J., & Hontecillas, R. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.04.003 · Cited by 100
Anti-inflammatory interventions of NF-κB signaling: Potential applications and risks
Senftleben, U. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.10.027 · Cited by 106
Adipose tissue inflammation in glucose metabolism
Kammoun, H. L., Kraakman, M. J., & Febbraio, M. A. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9274-4 · Cited by 112
Getting away from glucose: fanning the flames of obesity-induced inflammation
Shoelson, S. E., & Goldfine, A. B. (2009) · Nature Medicine · doi:10.1038/nm0409-373 · Cited by 98
Alzheimer’s Disease and Inflammaging
Kosyreva, A., Sentyabreva, A., Tsvetkov, I., & Makarova, O. (2022) · Brain Sciences · doi:10.3390/brainsci12091237 · Cited by 98
Innate Immune Signaling and Its Role in Metabolic and Cardiovascular Diseases
Xu, M. M., Liu, P. P., & Li, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00065.2017 · Cited by 108
Stressed out about obesity and insulin resistance
de Luca, C., & Olefsky, J. M. (2006) · Nature Medicine · doi:10.1038/nm0106-41 · Cited by 112
Self-citationZhang, Y., Li, Y., Niepel, M. W., Kawano, Y., Han, S., Liu, S., Marsili, A., Larsen, P. R., Lee, C.-H., & Cohen, D. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116011109 · Cited by 98
Zhou, J., Xu, G., Ma, S., Li, F., Yuan, M., Xu, H., & Huang, K. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.054 · Cited by 97
Aamir, K., Khan, H. U., Sethi, G., Hossain, M. A., & Arya, A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104602 · Cited by 101
Pancreatic islet inflammation in type 2 diabetes: From α and β cell compensation to dysfunction
Ehses, J. A., Ellingsgaard, H., Böni-Schnetzler, M., & Donath, M. Y. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450903025879 · Cited by 97
“Indeed, in other disease contexts tissue macrophages remove necrotic adipocytes and are thought to aid in adipose tissue remodelling in obesity (Strissel et al., 2007), but certain immune cells are eventually causal to tissue dysfunction over time (Arkan et al., 2005).”
BackgroundGhanim, H., Aljada, A., Daoud, N., Deopurkar, R., Chaudhuri, A., & Dandona, P. (2007) · Diabetologia · doi:10.1007/s00125-006-0508-9 · Cited by 96
Microvesicles and exosomes in metabolic diseases and inflammation
Dini, L., Tacconi, S., Carata, E., Tata, A. M., Vergallo, C., & Panzarini, E. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2019.12.008 · Cited by 103
Gögebakan, Ö., Osterhoff, M. A., Schüler, R., Pivovarova, O., Kruse, M., Seltmann, A.-C., Mosig, A. S., Rudovich, N., Nauck, M., & Pfeiffer, A. F. H. (2015) · Diabetologia · doi:10.1007/s00125-015-3618-4 · Cited by 95
Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity
Al-Gayyar, M. M. H., Abdelsaid, M. A., Matragoon, S., Pillai, B. A., & El‐Remessy, A. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01336.x · Cited by 97
Kallen, C., van Greevenbroek, M. M. J., Stehouwer, C. D. A., & Schalkwijk, C. G. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0400-4 · Cited by 107
KUO, J.-J., Chang, H., Tsai, T., & Lee, T.-Y. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1049 · Cited by 102
Nuclear receptors as drug targets for metabolic disease
Schulman, I. G. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.002 · Cited by 108
Stressed out about obesity: IRE1α–XBP1 in metabolic disorders
Sha, H., He, Y., Yang, L., & Qi, L. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.05.002 · Cited by 106
Yekollu, S. K., Thomas, R., & O’Sullivan, B. (2011) · Diabetes · doi:10.2337/db11-0275 · Cited by 92
Low molecular weight fucoidan attenuates liver injury via SIRT1/AMPK/PGC1α axis in db/db mice
Zheng, Y., Liu, T., Wang, Z., Xu, Y., Zhang, Q., & Luo, D. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.02.072 · Cited by 98
Tamura, Y., Sugimoto, M., Murayama, T., Minami, M., Nishikaze, Y., Ariyasu, H., Akamizu, T., Kita, T., Yokode, M., & Arai, H. (2010) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.3368 · Cited by 94
Inflammation Improves Glucose Homeostasis through IKKβ-XBP1s Interaction
Liu, J., Ibi, D., Taniguchi, K., Lee, J., Herrema, H., Akosman, B., Mucka, P., Salazar Hernandez, M. A., Uyar, M. F., Park, S. W., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.015 · Cited by 93
Self-citationYang, W., Jiang, W., & Guo, S. (2023) · Nutrients · doi:10.3390/nu15214671 · Cited by 117
Kurokawa, J., Nagano, H., Ohara, O., Kubota, N., Kadowaki, T., Arai, S., & Miyazaki, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101841108 · Cited by 91
Nie, X., Chen, H., Zhang, J., Zhang, Y., Yang, J., Pan, H., Song, W., Murad, F., He, Y., & Bian, K. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.167 · Cited by 96
Signaling pathways and intervention for therapy of type 2 diabetes mellitus
Cao, R. Y., Tian, H., Zhang, Y., Liu, G., Xu, H., Rao, G., Tian, Y., & Fu, X. (2023) · MedComm · doi:10.1002/mco2.283 · Cited by 109
Alam, M. A., & Rahman, M. M. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-13-60 · Cited by 91
Geng, S., Zhu, W., Xie, C., Li, X., Wu, J., Liang, Z., Xie, W., Zhu, J., Huang, C. X., Zhu, M., et al. (2015) · European Journal of Nutrition · doi:10.1007/s00394-015-0907-0 · Cited by 101
The Positive Effects of Yerba Maté (Ilex paraguariensis) in Obesity
Gambero, A., & Ribeiro, M. L. (2015) · Nutrients · doi:10.3390/nu7020730 · Cited by 124
Tantiwong, P., Shanmugasundaram, K., Monroy, A., Ghosh, S., Li, M., DeFronzo, R. A., Cersosimo, E., Sriwijitkamol, A., Mohan, S., & Musi, N. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00776.2009 · Cited by 91
Hafizi Abu Bakar, M., Kian Kai, C., Wan Hassan, W. N., Sarmidi, M. R., Yaakob, H., & Zaman Huri, H. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2601 · Cited by 91
Mostafalou, S., Eghbal, M. A., Nili‐Ahmadabadi, A., Baeeri, M., & Abdollahi, M. R. (2011) · Toxicology and Industrial Health · doi:10.1177/0748233711425073 · Cited by 100
“Interestingly, it has been shown (Arkan et al., 2005; Cai et al., 2005; Wullaert et al., 2007) that NF-kB activation in hepatocytes has a causative role in developing hepatic insulin resistance.”
BackgroundAdiponectin Resistance Exacerbates Insulin Resistance in Insulin Receptor Transgenic/Knockout Mice
Lin, H. V., Kim, J., Pocai, A., Rossetti, L., Shapiro, L. S., Scherer, P. E., & Accili, D. (2007) · Diabetes · doi:10.2337/db07-0127 · Cited by 97
Wang, X.-A., Zhang, R., Jiang, D., Deng, W., Zhang, S., Deng, S., Zhong, J., Wang, T., Zhu, L.-H., Yang, L., et al. (2013) · Hepatology · doi:10.1002/hep.26368 · Cited by 90
Li, C., Gao, J., Wan, X., Chen, Y., Xu, C., Feng, Z., Zeng, H., Lin, Y., Ma, H., Xu, P., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i34.5120 · Cited by 96
High-fat diets promote insulin resistance through cytokine gene expression in growing female rats
Johnson‐Flanagan, A. M., Brown, J. L., Santiago, C. A., Aad, P. Y., SPICER, L. J., & Spicer, M. T. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.06.005 · Cited by 103
Potential for therapeutic manipulation of the UPR in disease
Park, S. W., & Özcan, U. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0370-z · Cited by 105
Xu, L., Nagata, N., & Ota, T. (2018) · Adipocyte · doi:10.1080/21623945.2018.1474669 · Cited by 98
“factor-κB (NF-κB), leading to serine phosphorylation of the insulin receptor substrate that interferes with insulin action.(9,10) In addition, toll-like receptors (TLRs) play a”
BackgroundNutrition Regulates Innate Immunity in Health and Disease
Nobs, S. P., Zmora, N., & Elinav, E. (2020) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-120919-094440 · Cited by 102
Combined Interleukin-6 and Interleukin-1 Deficiency Causes Obesity in Young Mice
Chida, D., Osaka, T., Hashimoto, O., & Iwakura, Y. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1250 · Cited by 89
Obesity and sex interact in the regulation of Alzheimer's disease
Moser, V. A., & Pike, C. J. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.08.021 · Cited by 90
Free radicals, antioxidants, nuclear factor‐E2‐related factor‐2 and liver damage
Ramos‐Tovar, E., & Muriel, P. (2019) · Journal of Applied Toxicology · doi:10.1002/jat.3880 · Cited by 99
“…of lipids leads to increased ROS, which in turn induce activation of NF‐κB and the increased production of proinflammatory cytokines, including IL‐1β, TNF‐α and IL‐6 (which is also profibrogenic) (Arkan et al., 2005; Li, McGrath, Nammi, Heather, & Roufogalis, 2012; Magee, Zou, & Zhang, 2016).”
BackgroundBeraza, N., Malato, Y., Vander Borght, S., Liedtke, C., Wasmuth, H. E., Dreano, M., de Vos, R., Roskams, T., & Trautwein, C. (2008) · Gut · doi:10.1136/gut.2007.134288 · Cited by 87
Accelerated Tumor Formation in a Fatless Mouse with Type 2 Diabetes and Inflammation
Nunez, N. P., Oh, W.-J., Rozenberg, J., Perella, C., Anver, M., Barrett, J. C., Perkins, S. N., Berrigan, D., Moitra, J., Varticovski, L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4102 · Cited by 89
Gupte, A. A., Bomhoff, G. L., & Geiger, P. C. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00148.2008 · Cited by 87
A subcutaneous adipose tissue–liver signalling axis controls hepatic gluconeogenesis
Reilly, S. M., Ahmadian, M., Zamarron, B. F., Chang, L., Uhm, M., Poirier, B., Peng, X., Krause, D. M., Korytnaya, E., Neidert, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms7047 · Cited by 84
IKKβ phosphorylates p65 at S468 in transactivaton domain 2
Schwabe, R. F., & Sakurai, H. (2005) · The FASEB Journal · doi:10.1096/fj.05-3736fje · Cited by 84
N-3 Polyunsaturated Fatty Acids and Inflammation in Obesity: Local Effect and Systemic Benefit
Wang, Y., & Huang, F. (2015) · BioMed Research International · doi:10.1155/2015/581469 · Cited by 81
“NF-κB activation in hepatocytes [142], inactivation due to IKK-β deficiency in myeloid cells favors global insulin sensitivity [143].”
BackgroundXu, J., Morinaga, H., Oh, D., Li, P., Chen, A., Talukdar, S., Lazarowski, E. R., Olefsky, J. M., & Kim, J. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103207 · Cited by 93
Self-citationIκB kinase inhibitors for treating autoimmune and inflammatory disorders: potential and challenges
Strnad, J., & Burke, J. R. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.01.005 · Cited by 89
AMPK: mediating the metabolic effects of salicylate-based drugs?
Steinberg, G. R., Dandapani, M., & Hardie, D. G. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.06.002 · Cited by 83
Bertram, S., Brixius, K., & Brinkmann, C. K. (2016) · Endocrine · doi:10.1007/s12020-016-0976-8 · Cited by 94
The humoral side of insulin resistance
Lazar, M. A. (2006) · Nature Medicine · doi:10.1038/nm0106-43 · Cited by 95
Improved methodologies for the study of adipose biology: insights gained and opportunities ahead
Wang, Q. A., Scherer, P. E., & Gupta, R. K. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r046441 · Cited by 85
Li, Y., Gao, S., Shi, S., Xiao, D., Peng, S., Gao, Y., Zhu, Y. J., & Lin, Y. (2021) · Nano-Micro Letters · doi:10.1007/s40820-021-00614-6 · Cited by 92
Metadata
- Authors
- Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J., & Karin, M.
- Affiliations
- University of California San Diego (US)
- Moffitt Cancer Center (US)
- Ospedale San Luigi Gonzaga (IT)
- Corresponding author
- Olefsky, Jerrold
- Karin, Michael
- ORCID
- Venue
- Nature Medicine
- Published
- 2005-01-30
- Volume
- 11
- Issue
- 2
- Pages
- 191-198
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1991401793
- Cited by
- 1,773
- References
- 42
- Citations by year
- 2026: 23 · 2025: 41 · 2024: 47 · 2023: 50 · 2022: 64 · 2021: 54 · 2020: 74 · 2019: 77 · 2018: 83 · 2017: 69 · 2016: 82 · 2015: 100 · 2014: 113 · 2013: 129 · 2012: 123
- FWCI
- 67.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Funders
- National Institutes of Health
- University of California, San Diego
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 60484, DK-33651, K01DK060484)
- National Institute of Environmental Health Sciences (ES 06376, R01ES006376)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Pharmacology (medical) › Berberine and alkaloids research
- Keywords
- IKKβ, insulin resistance, obesity, inflammation, NF-κB, type 2 diabetes, hepatic insulin resistance, myeloid cells, high-fat diet, aging, skeletal muscle insulin sensitivity, adipose tissue insulin sensitivity
- MeSH terms
- Animals, Cells, Cultured, Dietary Fats, Glucose Tolerance Test, Inflammation, Insulin, Insulin Resistance, Obesity, Phenotype, Signal Transduction, Cytokines, NF-kappa B, Protein Serine-Threonine Kinases, Mice, Knockout, Myeloid Cells, Hepatocytes, Mice, I-kappa B Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.